Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q3 2024 Earnings Call Transcript November 7, 2024
Pacific Biosciences of California, Inc. beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.22.
Operator: Good day and welcome to the PacBio Third Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note...
